From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 2, 2009-02 ,pp. : 221-229

Bentham Science Publishers

Access to resources Recommend Favorite

Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-02 ,pp. : 487-496

Spandidos Publications

Access to resources Recommend Favorite

Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells

By                

International Journal of Oncology, Vol. 43, Iss. 1, 2013-01 ,pp. : 141-150

Spandidos Publications

Access to resources Recommend Favorite

Tyrosine kinase receptor expression in thymomas

By Henley John   Cummings Oscar   Loehrer   Sr. Patrick  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 4, 2004-04 ,pp. : 222-224

Springer Publishing Company

Access to resources Recommend Favorite

Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated β-catenin

By Herynk Matthew   Tsan Rachael   Radinsky Robert   Gallick Gary  

Clinical and Experimental Metastasis, Vol. 20, Iss. 4, 2003-06 ,pp. : 291-300

Springer Publishing Company

Access to resources Recommend Favorite